TuisBOT • ASX
add
Botanix Pharmaceuticals Ltd
Vorige sluiting
$0,047
Jaarwisseling
$0,045 - $0,49
Markkapitalisasie
102,17 m AUD
Gemiddelde volume
14,41 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (AUD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 8,25 m | 4 271,29% |
Bedryfskoste | 22,08 m | 41,82% |
Netto inkomste | -16,60 m | -7,47% |
Netto winsgrens | -201,11 | 97,54% |
Wins per aandeel | — | — |
EBITDA | -16,22 m | -5,12% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (AUD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 31,61 m | -34,73% |
Totale bates | 98,57 m | -0,88% |
Totale aanspreeklikheid | 44,58 m | 540,50% |
Totale ekwiteit | 54,00 m | — |
Uitstaande aandele | 1,97 mjd | — |
Prys om te bespreek | 1,57 | — |
Opbrengs op bates | -42,63% | — |
Opbrengs op kapitaal | -76,30% | — |
Kontantvloei
Netto kontantverandering
| (AUD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -16,60 m | -7,47% |
Kontant van bedrywe | -15,14 m | 0,95% |
Kontant van beleggings | -220,81 k | 48,29% |
Kontant van finansiering | -1,28 m | -738,08% |
Netto kontantverandering | -16,68 m | -8,04% |
Beskikbare kontantvloei | -7,24 m | -58,36% |
Meer oor
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Gestig
1984
Webwerf
Werknemers
11
